Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascentage
Biotech
Pfizer’s reputation wrangler plans departure—Chutes & Ladders
Pfizer’s longtime reputation wrangler plans departure. AI unicorn lassos new president. Jazz switches tempo with female CEO.
Darren Incorvaia
,
Zoey Becker
Jul 11, 2025 8:30am
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M debut
Jan 24, 2025 5:02am
BMS, Takeda's Chinese partners file for IPOs
Jan 22, 2025 6:11am
